AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine-related cancer 2012-06, Vol.19 (3), p.L25-L29
Hauptverfasser:	Kasuki, Leandro, Vieira Neto, Leonardo, Wildemberg, Luiz Eduardo A, Colli, Leandro Machado, de Castro, Margaret, Takiya, Christina M, Gadelha, Mônica R
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly - drug therapy Acromegaly - metabolism Adenoma - drug therapy Adenoma - metabolism Adult Antineoplastic Agents, Hormonal - therapeutic use Female Growth Hormone-Secreting Pituitary Adenoma - drug therapy Growth Hormone-Secreting Pituitary Adenoma - metabolism Humans Intracellular Signaling Peptides and Proteins - metabolism Male Middle Aged Octreotide - therapeutic use Pituitary Neoplasms Receptors, Somatostatin - metabolism to the Editor Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!